Exsurgo is a neuroscience company developing technologies to provide a wide range of neurological treatments, services and devices, underpinned by an AI-enabled, Cloud-based data analytics platform. 

Exsurgo’s immediate focus is on a range of services involving EEG (short for Electroencephalography) Neurofeedback, a long-established, non-invasive, drug-free therapy for a wide range of neurological conditions including chronic pain. 

The Axon headset is a custom-designed EEG headset (a Brain Computer Interface or BCI) that passively reads the bio-electrical activity associated with pain in the patient’s brain. 

Following a proof of concept trial completed in the UK, Exsurgo is now undertaking the largest clinical trial of its kind to prove the efficacy of Axon, in partnership with AUT and Waitemata District Health Board. The results from this trial are scheduled to published later in the year.  

www.exsurgo.com